XML 59 R39.htm IDEA: XBRL DOCUMENT
v3.25.2

Stockholders' Equity (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Stockholders' Equity Note [Abstract] |
Schedule of Activity of Restricted Stock Units | The following table summarizes the activity of RSUs and PRSUs during year ended June 30, 2025 (in thousands, except years and per share amounts):
|  |  |  |  |  | Weighted Average Grant-Date Fair Value |  | Weighted Average Remaining Contractual Term in Years
|  | Restricted Stock Units |  | Performance Restricted Stock Units |  | Restricted Stock Units |  | Performance Restricted Stock Units |  | Restricted Stock Units |  | Performance Restricted Stock Units
Outstanding at beginning of period |  | 791 |  |  | 348 |  |  | $ | 175.09 |  |  | $ | 204.02 |  |  | 1.6 |  | 1.7
Granted |  | 371 |  |  | 79 |  |  | 240.69 |  |  | 241.73 |  |  |  |  |
Vested* |  | (247) |  |  | (53) |  |  | 183.95 |  |  | 193.24 |  |  |  |  |
Forfeited |  | (82) |  |  | (32) |  |  | 181.27 |  |  | 187.33 |  |  |  |  |
Outstanding at end of period |  | 833 |  |  | 342 |  |  | $ | 201.05 |  |  | $ | 213.28 |  |  | 1.5 |  | 1.5
*Includes 53 thousand RSUs and 20 thousand PRSUs netted for tax.
Schedule of Option Activity | The following table summarizes option activity during the year ended June 30, 2025 (in thousands, except years and per share amounts):
| Options |  | Weighted Average Exercise Price |  | Weighted Average Remaining Contractual Term in Years
Outstanding at beginning of period | 786 |  |  | $ | 146.90 |  |  | 2.8
Granted | 35 |  |  | 249.56 |  |  |
Exercised | (293) |  |  | 105.35 |  |  |
Forfeited | (11) |  |  | 222.57 |  |  |
Outstanding at end of period | 517 |  |  | $ | 175.61 |  |  | 2.7
Options exercisable at end of period | 415 |  |  | $ | 169.87 |  |  | 2.0
Options vested and expected to vest at end of period | 512 |  |  | $ | 175.35 |  |  | 2.7
Schedule of Assumptions for Fair Value of Stock Option Plans and Purchase Rights Granted |
| 2025 |  | 2024 |  | 2023
Performance restricted stock units |  |  |  |  |
Weighted average grant date fair value | $272.47 |  | $168.14 |  | $208.40
Weighted average risk-free interest rate | 4.23% |  | 4.50% |  | 3.75%
Expected life in years | 3 - 4 |  | 3 - 4 |  | 4
Dividend yield(1) | 0.88% |  | 1.29% |  | 0.78% - 0.84%
Expected volatility | 32% - 34% |  | 31% - 36% |  | 32%
Average peer volatility(2) | 31% |  | 31% |  | —
Average peer correlation coefficient(3) | 0.5189 |  | 0.5385 |  | —
Stock options: |  |  |  |  |
Weighted average grant date fair value | $88.54 |  | $50.48 |  | $74.95
Weighted average risk-free interest rate | 4.17% |  | 4.44% |  | 3.85%
Expected life in years | 4.9 |  | 4.9 |  | 4.9
Dividend yield | 0.85% |  | 1.29% |  | 0.78%
Expected volatility | 37% |  | 36% |  | 34%
ESPP purchase rights: |  |  |  |  |
Weighted average grant date fair value | $59.55 |  | $47.40 |  | $52.38
Weighted average risk-free interest rate | 4.7% |  | 5.4% |  | 3.6%
Expected life in years | 0.5 |  | 0.5 |  | 0.5
Dividend yield | 0.87% - 0.90% |  | 0.75% - 1.30% |  | 0.75% - 0.84%
Expected volatility | 34% - 39% |  | 27% - 40% |  | 27% - 34%
(1) The dividend yield used to project the value of the stock delivered to the holder is based on historical dividends and the expectation of future dividend payouts. Total stockholder return is determined assuming the reinvestment of dividends over the performance period, which is mathematically equivalent to a 0% dividend yield. (2) The correlation coefficients are based upon the stock price data used to estimate the volatility assumptions. (3) The average peer volatility is estimated based upon the historical volatility of each peer company.
Schedule of Total Stock-Based Compensation Costs Incurred and Associated Tax Benefit Recognized | The following table summarizes total stock-based compensation costs incurred and the associated tax benefit recognized during the years ended June 30, 2025, 2024 and 2023 (in thousands):
| 2025 |  | 2024 |  | 2023
Cost of sales | $ | 8,945 |  |  | $ | 7,563 |  |  | $ | 6,465 |
Selling, general and administrative expenses | 64,588 |  |  | 58,149 |  |  | 53,049 |
Research and development expenses | 18,128 |  |  | 14,472 |  |  | 11,628 |
Stock-based compensation costs | 91,661 |  |  | 80,184 |  |  | 71,142 |
Tax benefit | (21,833) |  |  | (15,053) |  |  | (24,860) |
Stock-based compensation costs, net of tax benefit | $ | 69,828 |  |  | $ | 65,131 |  |  | $ | 46,282 |

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration